BFEC
XBI icon

Benjamin F. Edwards & Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Benjamin F. Edwards & Company’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$230K Buy
2,476
+1
+0% +$90 ﹤0.01% 873
2024
Q1 		$235K Sell
2,475
-55
-2% -$5.1K ﹤0.01% 856
2023
Q4 		$226K Sell
2,530
-60
-2% -$4.46K ﹤0.01% 846
2023
Q3 		$189K Hold
2,590
– – 0.01% 749
2023
Q2 		$215K Buy
2,590
+5
+0.2% +$418 0.01% 712
2023
Q1 		$197K Buy
2,585
+43
+2% +$3.57K 0.01% 727
2022
Q4 		$211K Hold
2,542
– – 0.01% 706
2022
Q3 		$202K Hold
2,542
– – 0.01% 675
2022
Q2 		$189K Hold
2,542
– – 0.01% 687
2022
Q1 		$228K Sell
2,542
-724
-22% -$66.9K 0.01% 647
2021
Q4 		$366K Buy
3,266
+200
+7% +$24.1K 0.02% 527
2021
Q3 		$385K Hold
3,066
– – 0.02% 505
2021
Q2 		$415K Sell
3,066
-335
-10% -$44K 0.02% 483
2021
Q1 		$461K Hold
3,401
– – 0.02% 480
2020
Q4 		$479K Hold
3,401
– – 0.03% 438
2020
Q3 		$379K Buy
3,401
+507
+18% +$56.8K 0.03% 452
2020
Q2 		$324K Buy
2,894
+919
+47% +$90.5K 0.02% 462
2020
Q1 		$153K Sell
1,975
-275
-12% -$24.4K 0.01% 572
2019
Q4 		$214K Hold
2,250
– – 0.02% 579
2019
Q3 		$172K Buy
2,250
+1,696
+306% +$141K 0.01% 596
2019
Q2 		$49K Sell
554
-1,113
-67% -$94.9K ﹤0.01% 911
2019
Q1 		$151K Hold
1,667
– – 0.01% 566
2018
Q4 		$120K Sell
1,667
-7,680
-82% -$619K 0.01% 614
2018
Q3 		$896K Buy
9,347
+1
+0% +$97 0.08% 246
2018
Q2 		$890K Buy
9,346
+969
+12% +$89.1K 0.09% 241
2018
Q1 		$735K Sell
8,377
-245
-3% -$22.4K 0.07% 259
2017
Q4 		$732K Sell
8,622
-239
-3% -$20K 0.08% 260
2017
Q3 		$767K Buy
8,861
+169
+2% +$13.5K 0.09% 218
2017
Q2 		$671K Buy
8,692
+346
+4% +$24.5K 0.09% 230
2017
Q1 		$579K Sell
8,346
-6,209
-43% -$417K 0.09% 241
2016
Q4 		$862K Buy
14,555
+7,878
+118% +$486K 0.14% 163
2016
Q3 		$443K Buy
6,677
+6,593
+7,849% +$408K 0.08% 240
2016
Q2 		$5K Hold
84
– – ﹤0.01% 913
2016
Q1 		$4K Hold
84
– – ﹤0.01% 959
2015
Q4 		$6K Sell
84
-9,585
-99% -$654K ﹤0.01% 952
2015
Q3 		$602K Sell
9,669
-69
-0.7% -$5.44K 0.13% 161
2015
Q2 		$819K Sell
9,738
-171
-2% -$13.3K 0.16% 135
2015
Q1 		$745K Buy
+9,909
New +$692K 0.16% 142
2014
Q2 		– Sell
-17,739
Closed -$842K – 950
2014
Q1 		$842K Sell
17,739
-339
-2% -$17.4K 0.23% 107
2013
Q4 		$785K Sell
18,078
-378
-2% -$15.6K 0.26% 105
2013
Q3 		$795K Buy
18,456
+213
+1% +$8.63K 0.29% 96
2013
Q2 		$634K Buy
+18,243
New +$641K 0.25% 106

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Benjamin F. Edwards & Company's XBI Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.04% in Q2 2024, buying an estimated $90 and bringing the position to 2,476 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Benjamin F. Edwards & Company first reported a position in XBI in Q2 2013 and has held it in 42 quarters since. The position peaked at $896K in Q3 2018. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • Benjamin F. Edwards & Company held 2,476 shares of State Street SPDR S&P Biotech ETF worth $230K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 1 State Street SPDR S&P Biotech ETF share in Q2 2024, an estimated $90.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #873 holding.
  • Benjamin F. Edwards & Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 42 quarters since.
  • Benjamin F. Edwards & Company's State Street SPDR S&P Biotech ETF position peaked at $896K in Q3 2018.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.